Cargando…
DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy
Historically the development of anticancer treatments has been focused on their effect on tumor cells alone. However, newer treatments have shifted attention to targets on immune cells, resulting in dramatic responses. The effect of DNA repair deficiency on the microenvironment remains an area of ke...
Autores principales: | Gilmore, Elaine, McCabe, Nuala, Kennedy, Richard D., Parkes, Eileen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607732/ https://www.ncbi.nlm.nih.gov/pubmed/31320901 http://dx.doi.org/10.1155/2019/4325105 |
Ejemplares similares
-
DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1
por: Martin, Sarah A., et al.
Publicado: (2010) -
The role of PTEN as a cancer biomarker
por: McCabe, Nuala, et al.
Publicado: (2016) -
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
por: Parkes, Eileen E., et al.
Publicado: (2016) -
DNA repair and breast cancer: therapeutic opportunities
por: Silver, DP
Publicado: (2011) -
IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin
por: O'Flanagan, Ciara H., et al.
Publicado: (2016)